David Mowry and J. Daniel Plants Share Letter of Support from Cutera Senior Leaders Sent to Company’s Board
Cutera, Inc. (NASDAQ: CUTR) announced support from its senior management for its current strategic path under CEO David Mowry and Executive Chairman J. Daniel Plants. The letter of support sent to the Board was signed by ten executives, highlighting concerns that ongoing board conflicts may harm the company’s operations and relationships with customers. They emphasized that the current strategic plan is effective, particularly the shift toward First mover devices like AviClear, which aligns with customer needs and drives transformation. The executives expressed their trust in Mowry's leadership and urged a quick resolution to board issues to prioritize customers and operational focus.
- Senior management supports the current strategic direction under CEO Mowry, indicating confidence in leadership.
- The shift towards 'First mover' devices like AviClear is seen as beneficial, potentially driving growth and improving profit margins.
- Management's emphasis on customer focus aligns with positive corporate culture and operational goals.
- Ongoing board conflicts may disrupt business operations and relationships with key customers and KOLs.
10 Executives – Including
Cutera Employees Highlight Danger of Disruption to Company’s Ability to Execute and to Valuable Relationships with Top Customers and KOLs
Recently,
The full letter is below:
The undersigned are members of Cutera’s senior management team. We respectfully write to you with only one goal: ensuring the future success of
As you might imagine, we have been extremely concerned to learn about the current public conflict regarding Cutera’s Board. We have fielded difficult calls from customers and industry KOLs and have struggled to answer questions from our worried employees. While we understand that matters at the Board level can be complicated, we respectfully ask that you consider the impact these issues are having on our ability to do our jobs effectively, deliver for our customers and manage our people.
With this in mind, we want to share three important points that we hope the Board will consider:
-
Cutera’s current strategic plan is working. While we believe change takes time to seep into the market, shifting our R&D investments to have “First mover” devices such as AviClear, aligns our business with that of our customers. Furthermore, the new business model is driving a true transformation of
Cutera . We can continue to evolve and develop from this point forward, engaging medical dermatologists in their space and looking to create and effectively expand our core customer group. The shift to more procedural revenue tightly aligns our interests with that of the practice. And we have gained a line of sight into how these model changes can and will accelerate the evolution ofCutera's financial profile to include faster growth, improving margins, and greater predictability in the future.
Now is the time to leverage our momentum to grow the business. We can do this by empowering the leadership team to make course corrections from the learnings gathered. We can move quickly and overcome pockets of resistance and push through recent headwinds due to macro challenges. We are confident that the road we are on is the right one.
-
Dave Mowry has earned our trust and respect since joiningCutera ;Dan Plants andDave Mowry are a highly cohesive and effective Executive team. Individually, they are visibly and completely committed to the Company, its people, and its customers. They are present and readily accessible to our employees, having invested the time to explain our shift in strategy and why it makes sense to the larger team. We respectfully urge you not to discount these relationships and the significant amount of goodwill they have engendered on behalf ofCutera over the last 12-15 months in particular.
- The physician-customers and the patients our products serve should come first. We respectfully ask you to resolve this issue as quickly as possible. Everything we do is ultimately to improve the lives of the patients that our products are used to treat. It’s not just good business; it is the mission on which Cutera’s culture is based. The sooner we can return to normal and fully focus on delivering our innovative products and services, the better for our employees, customers, and their patients.
Thank you for your consideration.
Sincerely,
Srinivas Pinapati, VP, Operations
TJ Huffman, VP, Capital Sales
Forward-Looking Statements and Third-Party Statements
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in any state to any person. This press release does not recommend the purchase or sale of a security. There is no assurance or guarantee with respect to the prices at which any securities of the Company will trade, and such securities may not trade at prices that may be implied herein. In addition, this press release and the discussions and opinions herein are for general information only, and are not intended to provide investment advice.
This press release contains forward-looking statements. Forward-looking statements are statements that are not historical facts and may include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans”, “will be” and similar expressions. Although
Funds managed by
Consequently, Voce Capital Management’s beneficial ownership of shares of, and/or economic interest in, the Company may vary over time depending on various factors, with or without regard to Voce Capital Management’s views of the Company’s business, prospects, or valuation (including the market price of the Company’s shares), including, without limitation, other investment opportunities available to
CERTAIN INFORMATION REGARDING THE PARTICIPANTS
The Voce Parties (as defined below), together with the other Participants (as defined below), intend to file a preliminary proxy statement and accompanying proxy card with the
THE PARTICIPANTS STRONGLY ADVISE ALL STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC’S WEBSITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST.
The Participants in the solicitation are anticipated to be: (i)
As of the date hereof, the Participants may be deemed to beneficially own (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934), in the aggregate, 1,483,632 shares of common stock, par value
Each of the Voce Parties expressly disclaims beneficial ownership of any Common Shares beneficially owned by
View source version on businesswire.com: https://www.businesswire.com/news/home/20230411005951/en/
Media
dzacchei@longacresquare.com / dreingold@longacresquare.com
Investor
emccarthy@dfking.com
Source: On behalf of
FAQ
What recent support did Cutera receive from its executives?
What does the letter from Cutera's senior employees emphasize?
How is Cutera's current strategic plan viewed by its management?